MedPath

The Impact of glutamine suppletion on outcome in patients undergoing high-risk cardiothoracic surgery.

Conditions
Infectious complications after high-risk cardiothoracic surgery.
MedDRA version: 8.1Level: LLTClassification code 10051284Term: Parenteral nutrition
Registration Number
EUCTR2006-004217-18-NL
Lead Sponsor
eiden University Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
80
Inclusion Criteria

•Patients with a left ventricular ejection fraction of <35%.
•Patients screened by the Mission! Heart Failure Program of the Leiden University Medical Center and scheduled for one of the surgical interventions in this program.

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

•Less than 18 years old
•Emergency operations
•Renal impairment as defined by a calculated creatinine clearance of < 25 mL/min using the Cockroft & Gault formula:
Crc (men) (ml/min)= [140-age (years)*Total body weight (kg)]/plasma creatinin (µmol/l)*1,23
Crc (women) (ml/min)= [140-age (years)*Total body weight (kg)]/plasma creatinin (µmol/l)*1,05
•Pregnancy

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath